Objective: The purpose of the present review is to analyze and summarize the feasibility, effectiveness, and safety of ultrasound-guided percutaneous microwave ablation (MWA) for adenomyosis according to largest studies available in current literature, so as to provide a more robust foundation for its use in the treatment of patients with this condition. Background: Adenomyosis is a common and frequently occurring gynecological disease. It can lead to clinical symptoms such as dysmenorrhea, menostaxis, menorrhagia, and anemia, and can seriously affect patients’ quality of life. Treatments for adenomyosis include drug, minimally invasive, and surgical therapies. Among them, ultrasound-guided percutaneous microwave ablation has become a new hotspot in the minimally invasive treatment of adenomyosis in recent years, with its advantages of small trauma and a good therapeutic effect. Methods: Relevant studies were retrieved from the CNKI (Chinese National Knowledge Infrastructure), CQVIP, Wanfang, PubMed, Web of Science, Cochrane Library, EMBASE, ClinicalTrials.gov, and Google Scholar databases. The retrieval time range was from January 2000 to June 2021. Chinese search terms included “adenomyosis”, “microwave ablation”, and “ultrasound”. English search terms included “microwave ablation”, “ultrasound”, “(adenomyosis) OR (endometrioma) OR (adenomyoma)”. Conclusions: Ultrasound-guided percutaneous microwave ablation therapy is a feasible, safe, and effective technique for the treatment of adenomyosis, and is worthy of clinical application and promotion.
CITATION STYLE
Zhang, S., Wang, K., Di, A., Yu, D., & Yao, T. (2021, November 1). Ultrasound-guided percutaneous microwave ablation of adenomyosis: a narrative review. Annals of Palliative Medicine. AME Publishing Company. https://doi.org/10.21037/APM-21-3133
Mendeley helps you to discover research relevant for your work.